# Filing Detail

Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001628280-25-008647
Filing Date
2025-02-27
Accepted
2025-02-27 16:11:43
Documents
21
Effectiveness Date
2025-02-27

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | S-3ASR | denalitherapeuticss-3asrx2.htm | S-3ASR | 323785
2 |  | dnlifilingfees.htm iXBRL | EX-FILING FEES | 46358
3 | EX-1.2 | exhibit12-sx3asr22725.htm | EX-1.2 | 267920
4 | EX-4.2 | exhibit42-sx3asr22725.htm | EX-4.2 | 377853
5 | EX-5.1 | exhibit51-sx3asr22725.htm | EX-5.1 | 27777
6 | EX-23.2 | exhibit232-sx3asr22725.htm | EX-23.2 | 2389
7 |  | dnlilogoa.jpg | GRAPHIC | 5258
8 |  | wilsonsonsiniloga2aa.jpg | GRAPHIC | 363953
9 |  | wilsonsonsinilogo1aa.jpg | GRAPHIC | 362252
| Complete submission text file | 0001628280-25-008647.txt |  | 2228317

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
23 | EXTRACTED XBRL INSTANCE DOCUMENT | dnlifilingfees_htm.xml | XML | 15167

Mailing Address 161 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 161 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 (650) 866-8547
Denali Therapeutics Inc. (Filer) CIK: 0001714899 (see all company filings)

EIN.: 463872213 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-285326 | Film No.: 25678858
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)